approval
saveEBGLYSS (LEBRIKIZUMAB-LBKZ) — FDA approval
community read0 votes
Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalSep 27, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalSep 27, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalSep 27, 2024
- approvalselpercatinib: RETEVMO (SELPERCATINIB) — FDA approvalSep 27, 2024
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalOct 18, 2024
- approvalZEPBOUND: ZEPBOUND (TIRZEPATIDE) — FDA approvalOct 18, 2024
comments(0)
5-min edit window · permanent after that